Cavalier Michael
Known title: EVP-General CounselCIK: 0001396621
Associated companies
Transaction History
| CNK | ▼ Sell | Other | 107,296 | $3.8M | 9/1/2026 | View on chart |
| CNK | ▼ Sell | Gift | 82,052 | $0 | 2/21/2026 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 2,445 | $65K | 2/21/2026 | View on chart |
| CNK | ▲ Buy | Grant | 107,876 | $2.8M | 2/20/2026 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 42,665 | $1.1M | 2/20/2026 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 4,717 | $124K | 2/20/2026 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 3,761 | $99K | 2/20/2026 | View on chart |
| CNK | ▲ Buy | Grant | 20,275 | $0 | 2/20/2026 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 442 | $13K | 7/28/2025 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 885 | $26K | 7/28/2025 | View on chart |
| CNK | ▼ Sell | Gift | 2,048 | $0 | 7/28/2025 | View on chart |
| CNK | ▼ Sell | Gift | 246,581 | $0 | 2/25/2025 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 3,167 | $87K | 2/23/2025 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 24,940 | $685K | 2/23/2025 | View on chart |
| CNK | ▲ Buy | Grant | 18,652 | $0 | 2/21/2025 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 4,716 | $135K | 2/20/2025 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 3,761 | $107K | 2/20/2025 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 4,020 | $133K | 2/19/2025 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 7,796 | $258K | 2/19/2025 | View on chart |
| CNK | ▼ Sell | Open Market | 2,797 | $98K | 12/6/2024 | View on chart |
| CNK | ▼ Sell | Open Market | 25,100 | $893K | 12/5/2024 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 3,166 | $51K | 2/23/2024 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 4,942 | $82K | 2/20/2024 | View on chart |
| CNK | ▲ Buy | Grant | 28,679 | $0 | 2/20/2024 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 2,066 | $34K | 2/19/2024 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 6,198 | $103K | 2/19/2024 | View on chart |
| CNK | ▼ Sell | Other | 11,814 | $0 | 2/19/2024 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 442 | $7K | 7/28/2023 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 3,166 | $40K | 2/23/2023 | View on chart |
| CNK | ▲ Buy | Grant | 35,958 | $0 | 2/20/2023 | View on chart |
| CNK | ▲ Buy | Option Exercise | 63,380 | $0 | 2/20/2023 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 1,898 | $22K | 2/19/2023 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 4,185 | $49K | 2/19/2023 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 5,125 | $60K | 2/19/2023 | View on chart |
| CNK | ▼ Sell | Other | 9,770 | $0 | 2/19/2023 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 4,154 | $71K | 8/19/2022 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 250 | $4K | 3/10/2022 | View on chart |
| CNK | ▲ Buy | Grant | 24,145 | $0 | 2/23/2022 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 1,152 | $21K | 2/18/2022 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 1,278 | $23K | 2/18/2022 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 3,074 | $55K | 2/18/2022 | View on chart |
| CNK | ▼ Sell | Other | 5,448 | $0 | 2/18/2022 | View on chart |
| CNK | ▼ Sell | Open Market | 8,929 | $146K | 12/20/2021 | View on chart |
| CNK | ▼ Sell | Tax Withholding | 5,810 | — | 12/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Cinemark stock rises on ScreenX expansion and higher Q3 revenue forecasts
Cinemark shares have gained 7.5% following announcements of ScreenX expansion and increased third-quarter revenue forecasts. The stock has also risen 12% over the past month, with analysts noting its premium format growth. Current trading levels remain below the average analyst target price of $40.27.
Cinemark stock rises on ScreenX expansion and higher Q3 revenue forecasts. Cinemark shares have gained 7.5% following announcements of ScreenX expansion and increased third-quarter revenue forecasts. The stock has also risen 12% over the past month, with analysts noting its premium format growth. Current trading levels remain below the average analyst target price of $40.27.